AKT

You have access
Nebivolol Sensitizes BT-474 Breast Cancer Cells to FGFR Inhibitors
YU JIN KIM, SE-KYEONG JANG, GYEONGMI KIM, SUNG-EUN HONG, CHAN SUB PARK, MIN-KI SEONG, HYUN-AH KIM, KWANG SEOK KIM, CHUN-HO KIM, KI SOO PARK, JUNGIL HONG, HYEON-OK JIN and IN-CHUL PARK

Anticancer Research May 2023, 43 (5) 1973-1980; DOI: https://doi.org/10.21873/anticanres.16357
You have access
LQB-118 Suppresses Migration and Invasion of Prostate Cancer Cells by Modulating the Akt/GSK3β Pathway and MMP-9/Reck Gene Expression
THIAGO MARTINO, GRAZIELE FREITAS DE BEM, SHIRLEY VANIA MOURA SANTOS, MARSEN GARCIA PINTO COELHO, ANGELA DE CASTRO RESENDE, CHAQUIP NETTO, PAULO ROBERTO RIBEIRO COSTA, GRAÇA JUSTO and KATIA COSTA DE CARVALHO SABINO

Anticancer Research January 2023, 43 (1) 359-367; DOI: https://doi.org/10.21873/anticanres.16171
You have access
Knockdown of NUPR1 Enhances the Sensitivity of Non-small-cell Lung Cancer Cells to Metformin by AKT Inhibition
YU JIN KIM, SUNG-EUN HONG, SE-KYEONG JANG, KI SOO PARK, CHUN-HO KIM, IN-CHUL PARK and HYEON-OK JIN

Anticancer Research July 2022, 42 (7) 3475-3481; DOI: https://doi.org/10.21873/anticanres.15834
You have access
Inactivation of AKT/ERK Signaling and Induction of Apoptosis Are Associated With Amentoflavone Sensitization of Hepatocellular Carcinoma to Lenvatinib
CHE-JUI YANG, MENG-HSUAN WU, JAI-JEN TSAI, FEI-TING HSU, TE-CHUN HSIA, KUO-CHING LIU and YU-CHENG KUO

Anticancer Research May 2022, 42 (5) 2495-2505; DOI: https://doi.org/10.21873/anticanres.15728
You have access
Molecular Mechanism Mediating Cytotoxic Activity of Cabazitaxel in Docetaxel-resistant Human Prostate Cancer Cells
HIROMITSU WATANABE, ASUKA KAWAKAMI, RYO SATO, KYOHEI WATANABE, YUTO MATSUSHITA and HIDEAKI MIYAKE

Anticancer Research August 2021, 41 (8) 3753-3758; DOI: https://doi.org/10.21873/anticanres.15167
You have access
Millettocalyxin B Inhibits Migratory Behavior of Lung Cancer Cells via Integrin α5 Suppression
PENNAPA LAFAUY, ARNON SILAPECH, NITHIKOON AKSORN, BOONCHOO SRITULARAK and PITHI CHANVORACHOTE

Anticancer Research August 2021, 41 (8) 3843-3849; DOI: https://doi.org/10.21873/anticanres.15177
You have access
Inhibition of AKT Enhances the Sensitivity of NSCLC Cells to Metformin
SE-KYEONG JANG, SUNG-EUN HONG, DA-HEE LEE, JI YEA KIM, JI-YOUNG KIM, JUNGIL HONG, IN-CHUL PARK and HYEON-OK JIN

Anticancer Research July 2021, 41 (7) 3481-3487; DOI: https://doi.org/10.21873/anticanres.15135
You have access
Lenvatinib Induces AKT/NF-κB Inactivation, Apoptosis Signal Transduction and Growth Inhibition of Non-small Cell Lung Cancer In Vivo
YU-CHANG LIU, FEI-TING HSU, JING-GUNG CHUNG, MAO-CHI WENG, CHIEN-YI TING, CHIA-JUNG TSAI, ALEXANDER LAN, JENG-YUAN WU, CHARLES CHUNG-WEI LIN and SONG-SHEI LIN

Anticancer Research June 2021, 41 (6) 2867-2874; DOI: https://doi.org/10.21873/anticanres.15068
You have access
Combined Targeting of AKT and mTOR Synergistically Inhibits Formation of Primary Colorectal Carcinoma Tumouroids In Vitro: A 3D Tumour Model for Pre-therapeutic Drug Screening
DOMINIK NÖRZ, CHRISTINA S. MULLINS, DANIEL J. SMIT, MICHAEL LINNEBACHER, GRITH HAGEL, ALP MIRDOGAN, JACQUELINE SIEKIERA, PATRICK EHM, JAKOB R. IZBICKI, ANDREAS BLOCK, OLE THASTRUP and MANFRED JÜCKER

Anticancer Research May 2021, 41 (5) 2257-2275; DOI: https://doi.org/10.21873/anticanres.15002
You have access
Lenvatinib Inhibits AKT/NF-κB Signaling and Induces Apoptosis Through Extrinsic/Intrinsic Pathways in Non-small Cell Lung Cancer
YU-CHANG LIU, BO-HAN HUANG, JING-GUNG CHUNG, WEI-LIN LIU, FEI-TING HSU and SONG-SHEI LIN

Anticancer Research January 2021, 41 (1) 123-130; DOI: https://doi.org/10.21873/anticanres.14757

Main menu

User menu

Search

AKT

Pages